PHARMACOKINETICS OF MITOXANTRONE IN MAN AND LABORATORY-ANIMALS

被引：49

作者：

BATRA, VK

MORRISON, JA

WOODWARD, DL

SIVERD, NS

YACOBI, A

机构：

来源：

关键词：

D O I：

10.3109/03602538608998294

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：311 / 329

页数：19

共 28 条

[1] DISPOSITION OF MITOXANTRONE IN PATIENTS
ALBERTS, DS
PENG, YM
LEIGH, S
DAVIS, TP
WOODWARD, DL
[J]. CANCER TREATMENT REVIEWS, 1983, 10 : 23 - 27
[2] ALBERTS DS, 1985, CANCER RES, V45, P1879
[3] PHASE-I CLINICAL-TRIAL OF MITOXANTRONE - A NEW ANTHRACENEDIONE ANTI-CANCER DRUG
ALBERTS, DS
GRIFFITH, KS
GOODMAN, GE
HERMAN, TS
MURRAY, E
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 5 (01) : 11 - 15
[4] ALBERTS DS, 1983, 13TH INT C CHEM VIEN, V212, P14
[5] BATRA VK, 1984, ABSTR APHA AC PHARM, V14, P106
[6] COMPARISON OF ANTI-NEOPLASTIC ACTIVITY OF AMINOETHYLAMINOANTHRAQUINONES AND ANTHRACYCLINE ANTIBIOTICS
CHENG, CC
ZBINDEN, G
ZEECHENG, RKY
[J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (03) : 393 - 396
[7] CHICCARELLI FS, 1984, AM PHARM ASS, V14, P252
[8] CHLEBOWSKI R, 1985, ADV CANCER CHEMOTHER
[9] COMMENT ON MITOXANTRONE
DUKART, G
IATROPOULOS, MJ
YACOBI, A
[J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (03): : 216 - 218
[10] ESTEY EH, 1982, P AM ASSOC CANC RES, V23, P113